Results 111 to 120 of about 216,096 (151)
Retraction Note: Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy. [PDF]
Acta Neuropathol CommunValera E +8 more
europepmc +1 more source
Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study. [PDF]
Ann NeurolFabbri M +26 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2022
Multiple system atrophy (MSA) is a rare neurodegenerative disease that is characterized by neuronal loss and gliosis in multiple areas of the central nervous system including striatonigral, olivopontocerebellar and central autonomic structures.
Werner Poewe +8 more
openaire +4 more sources
Multiple system atrophy (MSA) is a rare neurodegenerative disease that is characterized by neuronal loss and gliosis in multiple areas of the central nervous system including striatonigral, olivopontocerebellar and central autonomic structures.
Werner Poewe +8 more
openaire +4 more sources
Physical Therapy, 1999 Multiple system atrophy is a neurological disorder that has gone unrecognized for too long due to its involvement across multiple regions of the central nervous system. This disorder is finally being unveiled through increased reporting in the scientific literature.
L, Swan, J, Dupont
exaly +7 more sources
Continuum
This article provides up-to-date diagnosis and management concepts for patients with multiple system atrophy, a rare, sporadic, adult-onset, progressive, and fatal neurodegenerative disorder that is characterized mainly by autonomic and motor dysfunction.Making an accurate and early diagnosis of multiple system atrophy remains challenging because of ...
Khemchand R. Surana +6 more
+6 more sources
This article provides up-to-date diagnosis and management concepts for patients with multiple system atrophy, a rare, sporadic, adult-onset, progressive, and fatal neurodegenerative disorder that is characterized mainly by autonomic and motor dysfunction.Making an accurate and early diagnosis of multiple system atrophy remains challenging because of ...
Khemchand R. Surana +6 more
+6 more sources
The Lancet Neurology, 2004
Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder characterised clinically by any combination of parkinsonian, autonomic, cerebellar, or pyramidal signs and pathologically by cell loss, gliosis, and glial cytoplasmic inclusions in several CNS structures.
Gregor K, Wenning +3 more
openaire +2 more sources
Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder characterised clinically by any combination of parkinsonian, autonomic, cerebellar, or pyramidal signs and pathologically by cell loss, gliosis, and glial cytoplasmic inclusions in several CNS structures.
Gregor K, Wenning +3 more
openaire +2 more sources
Seminars in Neurology, 2014
Multiple system atrophy (MSA) is a rare adult-onset synucleinopathy associated with dysautonomia and the variable presence of poorly levodopa-responsive parkinsonism and/or cerebellar ataxia. Other clinical symptoms that can be associated with MSA include hyperreflexia, stridor, sleep apnea, and rapid eye movement sleep behavior disorder (RBD).
openaire +2 more sources
Multiple system atrophy (MSA) is a rare adult-onset synucleinopathy associated with dysautonomia and the variable presence of poorly levodopa-responsive parkinsonism and/or cerebellar ataxia. Other clinical symptoms that can be associated with MSA include hyperreflexia, stridor, sleep apnea, and rapid eye movement sleep behavior disorder (RBD).
openaire +2 more sources
Current Opinion in Neurology, 1995
The past year has seen advances in delineating the clinical features, natural history and imaging characteristics of multiple system atrophy. The initiating pathogenetic mechanisms remain unknown. However, any aetiological or pathophysiological hypothesis must consider not only neuronal loss and gliosis but also the recently described characteristic ...
N, Quinn, G, Wenning
openaire +4 more sources
The past year has seen advances in delineating the clinical features, natural history and imaging characteristics of multiple system atrophy. The initiating pathogenetic mechanisms remain unknown. However, any aetiological or pathophysiological hypothesis must consider not only neuronal loss and gliosis but also the recently described characteristic ...
N, Quinn, G, Wenning
openaire +4 more sources
Young-onset multiple system atrophy
Journal of the Neurological Sciences, 2012Han-Joon Kim +2 more
exaly +4 more sources
The Neurologist, 2008
It has been almost 4 decades since the descriptions of the 3 parts of multiple system atrophy (MSA) have taken place, characterized clinically by dysautonomia, parkinsonism, and cerebellar dysfunction. The discovery of a distinctive pathologic maker has finally provided the conceptual synthesis of these 3 entities into the universal designation of MSA ...
Roongroj, Bhidayasiri, Helen, Ling
openaire +2 more sources
It has been almost 4 decades since the descriptions of the 3 parts of multiple system atrophy (MSA) have taken place, characterized clinically by dysautonomia, parkinsonism, and cerebellar dysfunction. The discovery of a distinctive pathologic maker has finally provided the conceptual synthesis of these 3 entities into the universal designation of MSA ...
Roongroj, Bhidayasiri, Helen, Ling
openaire +2 more sources